Morphine Completed Phase 1 Trials for Drug withdrawal syndrome neonatal Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01671410Buprenorphine for Treatment of Neonatal Abstinence Syndrome in Infants With In Utero Exposure to Benzodiazepines
NCT00521248Buprenorphine for the Treatment of Neonatal Abstinence Syndrome